The Minister of Health, Alexandru Rogobete, emphasized that it is crucial for Romania to strengthen its capacity to produce safe medicines and that it is time to strategically invest in domestic medicine production.

Romania aims to enhance and consolidate its capacity for drug production through the project 'Inova A+ Research and Development Center and Production of Critical Medicines', initiated by Antibiotice Iași with the support of the Ministry of Health and the Ministry of European Funds.

This project, launched through the STEP program, will transform Antibiotice Iași into a national hub for pharmaceutical innovation, aiming to develop critical medicines and advanced therapeutic solutions.

The Minister of Health, Alexandru Rogobete, emphasized the importance of the company, which ranks among the top five globally in the pharmaceutical sub-industry, according to sustainability indicators.

Antibiotice Iași has a production capacity of over 480 million tablets annually and is a world leader in the production of Nystatin.

The company has an international presence in over 50 countries and a market capitalization of 1.73 billion lei.